quipazine has been researched along with glutamic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
| Glass, JD; Hauser, UE; Rea, MA; Selim, M | 1 |
| Amos-Kroohs, RM; Braun, AA; Grace, CE; Graham, DL; Schaefer, TL; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
3 other study(ies) available for quipazine and glutamic acid
| Article | Year |
|---|---|
Cardiovascular effects of microinjections of quipazine into nuclei of the medulla oblongata in anaesthetized cats: comparison with L-glutamate.
Topics: Anesthesia; Animals; Blood Pressure; Cats; Female; Glutamates; Glutamic Acid; Heart Rate; Hemodynamics; Male; Medulla Oblongata; Microinjections; Neurons; Quipazine; Serotonin Antagonists; Sympathetic Nervous System | 1992 |
Serotonergic inhibition of light-induced fos protein expression and extracellular glutamate in the suprachiasmatic nuclei.
Topics: Animals; Cricetinae; Glutamates; Glutamic Acid; Immunohistochemistry; Male; Mesocricetus; Nerve Tissue Proteins; Photic Stimulation; Proto-Oncogene Proteins c-fos; Quipazine; Serotonin; Suprachiasmatic Nucleus | 1993 |
Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.
Topics: Analysis of Variance; Animals; Animals, Newborn; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Male; Methamphetamine; Motor Activity; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors | 2013 |